SciDev (ASX:SDV) share price on watch after winning tender process with Fortescue (ASX:FMG)

The SciDev Ltd (ASX: SDV) share price will be one to watch today after announcing a deal with Fortescue Metals.

| More on:
Man with binoculars standing on edge of building looking into distance

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The SciDev Ltd (ASX: SDV) share price will be one to watch today. The chemical engineering company announced a partnership with Fortescue Metals Group Limited (ASX: FMG).

Yesterday, the share price closed up 0.7% to finish at 68 cents. In comparison, the S&P/ASX All Ordinaries Index finished 0.4% higher.

Let's take a closer look at what's in the new deal.

The SciDev/Fortescue deal

In a statement to the ASX, SciDev announced it would "participate in a commercial trial" with Fortescue Metals. The trial will last one week and be conducted at the Fortescue Solomon Hub in the Pilbara region, Western Australia.

SciDev won the contract through a competitive tender process. Fortescue will pay the company $60,000 for its time.

Fortescue will be trialling SciDev's MaxiFloat technology. According to SciDev's website, MaxiFloat is a range of products intended for the treatment of wastewater in the mining, and oil and gas industries.

Commenting on the deal, SciDev Managing Director and CEO, Lewis Utting said:

The agreement with Fortescue further extends the presence of SciDev chemistry and services across major mining projects in Australia. With water being a premium commodity in the Pilbara, SciDev's technology can add real benefit to our customers as well as reduce their environmental footprint. The continued growth of SciDev and our ability to work with and service major mining companies such as Fortescue highlights the caliber of the SciDev team in executing the technical and commercial evaluations with our customers.

What is mining wastewater and why does it need to be treated?

According to the Commonwealth Scientific and Industrial Research Organisation (CSIRO), mining is very water-intensive. Some the ways water is used in the industry include:

  • transportation of ore and waste in slurries
  • separation of materials with chemical agents, and
  • suppression of dust during processing and transportation.

Water is a scarce resource in Australia. Governments and the industry at large strongly encourage water recycling when possible. Through the mining process, however, water will become polluted. This is why it needs to be contained and treated before it can be recycled back into the environment.

SciDev and Fortescue share price snapshots

At its current level of 68 cents, SciDev's share price is on an upward path. This time last year, shares in the company were selling at 57 cents. In the general panic of COVID-19 the share price reached a low of 25 cents.

Fortescue's share price, similarly, is also trending in the right direction. Just 12 months ago, shares in the miner cost an investor $8.58 each. As of yesterday, the share price was $22.18. That's an impressive 142.1% gain over 52 weeks.

The respective market capitalisations of SciDev and Fortescue Metals are $104.2 million and $68.3 billion.

Should you invest $1,000 in Immuron Limited right now?

Before you buy Immuron Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Immuron Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough trading day for ASX stocks this Monday.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in May

These stocks could be best buys this month according to the broker.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Oil worker using a smartphone in front of an oil rig.
Energy Shares

ASX 200 energy shares plunge on shock OPEC move

ASX 200 energy shares like Woodside and Santos are tumbling on Monday. Let’s find out why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why 4DMedical, Gold Road, Syrah, and Tyro shares are racing higher today

These shares are starting the week strongly. But why?

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Gold

2 ASX gold stocks racing higher in Monday's sinking market

Investors are sending these ASX gold stocks flying higher on Monday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Brainchip, Helia Group, Reliance Worldwide, and Westpac shares are dropping today

These shares are starting the week in the red. But why?

Read more »

Man looking upwards contemplating which shares to buy
Broker Notes

CSL shares have climbed 10% since 11 April. Is it too late to buy?

What are analysts saying about this biotech giant after its recent rally? Let's find out.

Read more »